Fatal lymphoproliferative disease as a complication of Evans syndrome

Area of Science:

• Pediatric Hematology
• Infectious Diseases
• Immunology

Background:

• Evans syndrome is an autoimmune disorder characterized by co-occurring hemolytic anemia and immune thrombocytopenia.
• While typically managed with immunosuppression, rare complications can arise, particularly in infants.
• The Epstein-Barr virus (EBV) is a common herpesvirus known to cause lymphoproliferative disorders in immunocompromised individuals.

Observation:

• A 9-month-old infant presented with bruising and petechiae, diagnosed with Coombs-positive hemolytic anemia and immune thrombocytopenia (Evans syndrome).
• Despite treatment with intravenous immunoglobulin and steroids, the infant developed fevers, hepatosplenomegaly, pulmonary nodules, and central nervous system lesions.
• Lung biopsy revealed polyclonal lymphoproliferative disease with detectable Epstein-Barr viral genomes.

Findings:

• The infant's condition progressed to fatal lung disease, 6 months after the initial Evans syndrome diagnosis.
• The findings indicate a link between Evans syndrome and the development of Epstein-Barr virus-driven polyclonal lymphoproliferation.
• This case demonstrates a rare but severe complication of immune dysregulation in infancy.

Implications:

• This case underscores the importance of monitoring for lymphoproliferative disorders in infants diagnosed with Evans syndrome, especially if they exhibit persistent or worsening symptoms.
• It suggests that EBV may play a significant role in the pathogenesis of lymphoproliferative disease in the context of immune dysregulation, even without overt immunosuppression.
• Further research is warranted to understand the mechanisms underlying EBV-associated lymphoproliferation in Evans syndrome and to explore potential diagnostic and therapeutic strategies.